SCHEMBL7922762

SCHEMBL7922762

Fc1ccc(OC(F)(F)COC(F)(F)F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.37
▸ GPR3 P46089 1/20 0.35
▸ CASR P41180 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ MAOB P27338 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ APP P05067 1/20 0.32
▸ EPHX2 P34913 1/20 0.32
▸ POLB P06746 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ KIF11 P52732 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL255560 0.75 GPR3 (0.52) GAAGPR3CASRHSD11B1SLC6A2
SCHEMBL2341406 0.75 GAA (0.42) GAAGPR3CASRHSD11B1MAOB
SCHEMBL15235976 0.74 DRD2 (0.49) CASRMAOBMAPTAPPMEN1
SCHEMBL2346377 0.73 CA2 (0.37) GAAKMT2AKIF11
SCHEMBL31507924 0.72 GAA (0.40) GAAGPR3CASRHSD11B1MAOB
SCHEMBL7937983 0.70 GPR3 (0.47) GAAGPR3CASRHSD11B1SLC6A2
SCHEMBL7938385 0.70 KIF11 (0.50) GAAGPR3HSD11B1MAPTEPHX2
SCHEMBL7929139 0.69 SLC6A4 (0.50) GAAGPR3CASRSLC6A4MAPT
SCHEMBL19477799 0.67 GAA (0.42) GAAGPR3CASRHSD11B1SLC6A2
SCHEMBL10603546 0.67 GAA (0.42) GAAGPR3HSD11B1MAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010056877-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY, INC. (US) 2010-05-20 — — WO disclosed
Send feedback